Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Case Report: Metreleptin Treatment in a Patient With a Novel Mutation for Familial Partial Lipodystrophy Type 3, Presenting With Uncontrolled Diabetes and Insulin Resistance
Authors
Keywords
-
Journal
Frontiers in Endocrinology
Volume 12, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-06-08
DOI
10.3389/fendo.2021.684182
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Efficacy of metreleptin treatment in familial partial lipodystrophy due to PPARG versus LMNA pathogenic variants
- (2019) Hilal Sekizkardes et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Comorbidities and Survival in Patients with Lipodystrophy: An International Chart Review Study
- (2019) Baris Akinci et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metreleptin-mediated improvements in insulin sensitivity are independent of food intake in humans with lipodystrophy
- (2018) Rebecca J. Brown et al. JOURNAL OF CLINICAL INVESTIGATION
- Beneficial effects of leptin substitution on impaired eating behavior in lipodystrophy are sustained beyond 150 weeks of treatment
- (2018) Janett Püschel et al. CYTOKINE
- Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease
- (2018) Iram Hussain et al. PATHOLOGY
- Clinical presentations, metabolic abnormalities and end-organ complications in patients with familial partial lipodystrophy
- (2017) Baris Akinci et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Leptin Substitution in Patients With Lipodystrophy: Neural Correlates for Long-term Success in the Normalization of Eating Behavior
- (2016) Haiko Schlögl et al. DIABETES
- The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline
- (2016) Rebecca J. Brown et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Partial and Generalized Lipodystrophy: Comparison of Baseline Characteristics and Response to Metreleptin
- (2015) Talia Diker-Cohen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Congenital generalized lipodystrophies—new insights into metabolic dysfunction
- (2015) Nivedita Patni et al. Nature Reviews Endocrinology
- The Subtle Balance between Lipolysis and Lipogenesis: A Critical Point in Metabolic Homeostasis
- (2015) Chiara Saponaro et al. Nutrients
- Menopausal Status and Abdominal Obesity Are Significant Determinants of Hepatic Lipid Metabolism in Women
- (2015) Leanne Hodson et al. Journal of the American Heart Association
- The Clinical Approach to the Detection of Lipodystrophy – An AACE Consensus Statement
- (2015) Yehuda Handelsman et al. Endocrine Practice
- Clinical and molecular characterization of a severe form of partial lipodystrophy expanding the phenotype of PPARγ deficiency
- (2012) Philippe M. Campeau et al. JOURNAL OF LIPID RESEARCH
- Efficacy of leptin therapy in the different forms of human lipodystrophy
- (2009) A. Y. Chong et al. DIABETOLOGIA
- Fatty Acid Metabolism in Patients with PPARγ Mutations
- (2008) Garry D. Tan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Leptin therapy for partial lipodystrophy linked to a PPAR-γ mutation
- (2007) Jean-Marc Guettier et al. CLINICAL ENDOCRINOLOGY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started